在临床试验中评估治疗效果的收缩估计器
Erik W van Zwet1, Lu Tian2, Robert Tibshirani2,3
1Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
Statistics in medicine
|December 19, 2023
概括
临床试验通常具有较低的信号噪声比 (SNR),导致功率低. 一个新的收缩估计器减少了过度乐观,并改善了重要的试验结果的信心区间覆盖率.
科学领域:
- 临床试验和生物统计学
- 基于证据的医学基于证据的医学.
- 进行元分析分析.
背景情况:
- 临床试验的目的是估计对照条件的治疗效果.
- 低信号噪声比 (SNR) 在临床试验中很常见,表明统计能力低.
- 系统审查 (CDSR) 的Cochrane数据库为分析试验特征提供了丰富的来源.
研究的目的:
- 在临床试验中使用CDSR.的元分析量化评估低SNR的后果.
- 评估一种新型收缩估计器与治疗效果估计的传统公正估计器的性能.
- 解决"赢家的诅咒"现象,其特点是过度乐观和统计学意义上的试验覆盖不足.
主要方法:
- 在 Cochrane 系统性审查数据库 (CDSR) 中对临床试验的分析.
- 信号与噪声比率 (SNR) 分布的定量评估.
- 将新型收缩估计器与标准无偏估计器进行比较,使用诸如根平均平方误差,覆盖率和偏差等指标.
主要成果:
- 临床试验经常表现出低SNR,这意味着没有足够的功率来检测真正的治疗效果.
- 从统计学上显著的试验显示了对效果估计的过度乐观以及对置信区间的覆盖不足.
- 拟议的收缩估计器在减少偏差和提高准确性方面,在显著性上有条件和无条件地表现出优于公正估计器的性能.
结论:
- 低SNR是临床试验中普遍存在的问题,影响治疗效果估计的可靠性.
- "胜利者的诅咒"影响了重要的试验结果,需要改进估计方法.
- 新型收缩估计器提供了一个强大的解决方案,以减轻过度乐观,并提高临床试验研究中治疗效果大小的精度.
相关概念视频
01:52Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
01:19Testing a Claim about Standard Deviation
2.5K
A complete procedure to test a claim about population standard deviation or population variance is explained here.
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
2.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
00:57Behrens–Fisher Test
81
The Behrens-Fisher test is a statistical method designed to address the Behrens-Fisher problem, which arises when comparing the means of two normally distributed populations with unequal variances. Unlike the Student's t-test, which assumes equal variances, the Behrens-Fisher test allows for mean comparison without this restrictive assumption. This flexibility makes it particularly valuable in scenarios where two independent samples exhibit normality but lack variance homogeneity.
This test...
This test...
81
01:24Kaplan-Meier Approach
150
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
150
01:20Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195